Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents.


Journal

Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203

Informations de publication

Date de publication:
Dec 2022
Historique:
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 5 10 2022
Statut: ppublish

Résumé

The group of 18 new amide derivatives of mycophenolic acid (MPA) and selected heterocyclic amines was synthesised as potential immunosuppressive agents functioning as inosine-5'-monophosphate dehydrogenase (IMPDH) uncompetitive inhibitors. The synthesis of 14 of them employed uronium-type activating system (TBTU/HOBt/DIPEA) while 4 of them concerned phosphonic acid anhydride method (T3P/Py) facilitating amides to be obtained in moderate to excellent yields without the need of phenolic group protection. Most of optimised protocols did not require complicated reaction work-ups, including chromatographic, solvent-consuming methods. The biological activity assay was performed on the T-Jurkat cell line and peripheral mononuclear blood cells (PBMCs) which are both dedicated for antiproliferative activity determination. Each of designed derivatives was characterised by reduced cytotoxicity and benzoxazole analogue (

Identifiants

pubmed: 36189734
doi: 10.1080/14756366.2022.2127701
pmc: PMC9542285
doi:

Substances chimiques

Amides 0
Amines 0
Anhydrides 0
Benzoxazoles 0
Enzyme Inhibitors 0
Immunosuppressive Agents 0
Solvents 0
Inosine 5A614L51CT
IMP Dehydrogenase EC 1.1.1.205
Mycophenolic Acid HU9DX48N0T

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2725-2741

Références

Cell. 1996 Jun 14;85(6):921-30
pubmed: 8681386
Chem Rev. 2011 Nov 9;111(11):6557-602
pubmed: 21866984
Med Chem. 2013 Dec;9(8):1051-7
pubmed: 23521008
Front Immunol. 2017 Dec 21;8:1870
pubmed: 29312346
Eur J Pharmacol. 2020 Nov 15;887:173580
pubmed: 32949604
J Enzyme Inhib Med Chem. 2020 Dec;35(1):265-279
pubmed: 31790602
Acta Pharm. 2014 Dec;64(4):419-31
pubmed: 25531783
Bioorg Med Chem Lett. 2013 Sep 15;23(18):5140-4
pubmed: 23937979
Eur J Med Chem. 2013 Apr;62:785-98
pubmed: 23333063
Int J Cancer. 2020 Jun 15;146(12):3397-3409
pubmed: 31609477
Eur J Med Chem. 2020 Mar 1;189:112091
pubmed: 32007665
Bioorg Med Chem Lett. 2014 Jan 1;24(1):332-6
pubmed: 24269162
Medchemcomm. 2019 May 2;10(8):1290-1301
pubmed: 31534651
Cochrane Database Syst Rev. 2015 Dec 03;(12):CD007746
pubmed: 26633102
Curr Med Chem. 2010;17(18):1926-41
pubmed: 20377512
Bioorg Med Chem Lett. 2003 Feb 24;13(4):657-60
pubmed: 12639552
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Asian Nat Prod Res. 2019 Feb;21(2):178-185
pubmed: 29607657
RSC Adv. 2021 Nov 1;11(55):34938-34944
pubmed: 35494752
Chem Rev. 2009 Jul;109(7):2903-28
pubmed: 19480389
Bioorg Med Chem. 2010 Nov 15;18(22):8106-11
pubmed: 20934342
J Med Chem. 2014 Dec 26;57(24):10257-74
pubmed: 25255204
Br J Clin Pharmacol. 2022 Feb;88(2):476-489
pubmed: 34240462
Molecules. 2015 Sep 16;20(9):16852-91
pubmed: 26389876
Neurosurg Focus. 2015 Mar;38(3):E12
pubmed: 25727221
ChemMedChem. 2010 Apr 6;5(4):591-7
pubmed: 20157916
Bioorg Med Chem Lett. 2007 Aug 1;17(15):4208-12
pubmed: 17532630
Front Public Health. 2021 Mar 31;9:671316
pubmed: 33869136
J Enzyme Inhib Med Chem. 2015;30(4):550-63
pubmed: 25198892
Eur J Med Chem. 2020 Sep 15;202:112502
pubmed: 32652407
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Biosci Biotechnol Biochem. 2008 Oct;72(10):2623-31
pubmed: 18838793
Mol Pharm. 2015 Dec 7;12(12):4445-53
pubmed: 26529468
Int J Pept Protein Res. 1991 Apr;37(4):252-6
pubmed: 1894440
Chem Rev. 2000 Oct 11;100(10):3801-26
pubmed: 11749328
J Med Chem. 2013 May 23;56(10):4028-43
pubmed: 23668331
Eur J Med Chem. 2018 Jan 1;143:646-655
pubmed: 29216563
J Enzyme Inhib Med Chem. 2016 Dec;31(6):974-82
pubmed: 26308114
Eur J Med Chem. 2018 Oct 5;158:286-301
pubmed: 30223117
Int Immunopharmacol. 2017 Mar;44:137-142
pubmed: 28092865
Nat Prod Res. 2020 May;34(9):1206-1212
pubmed: 30760051
Bioorg Med Chem Lett. 2020 Dec 15;30(24):127543
pubmed: 32931912
J Enzyme Inhib Med Chem. 2018 Dec;33(1):972-977
pubmed: 29792360

Auteurs

Juliusz Maksymilian Walczak (JM)

Department of Organic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Poland.

Dorota Iwaszkiewicz-Grześ (D)

Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.

Michalina Ziomkowska (M)

Perlan Technologies sp. z o.o, Warszawa, Poland.

Magdalena Śliwka-Kaszyńska (M)

Department of Organic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Poland.

Mateusz Daśko (M)

Department of Inorganic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Poland.

Piotr Trzonkowski (P)

Department of Medical Immunology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.

Grzegorz Cholewiński (G)

Department of Organic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, Gdańsk, Poland.

Articles similaires

Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans
Adult Aged Female Humans Male
Humans Lupus Erythematosus, Systemic Molecular Targeted Therapy Animals Immunosuppressive Agents
Cryoelectron Microscopy Ribonucleotide Reductases Escherichia coli Catalytic Domain Cytidine Diphosphate

Classifications MeSH